Back To Top
Business

Samsung Biologics Q4 net income down 54.3% to W96.2b

This undated photo, provided by Samsung Biologics, shows one of its three plants in Songdo in Incheon. (Samsung Biologics)
This undated photo, provided by Samsung Biologics, shows one of its three plants in Songdo in Incheon. (Samsung Biologics)
Samsung Biologics Co. on Tuesday reported its fourth-quarter net profit of 96.2 billion won ($87 million), down 54.3 percent from a year earlier.

The company said in a regulatory filing that operating income for the October-December period fell 13.4 percent on-year to 92.6 billion won. Sales increased 19.8 percent to 375.3 billion won. (Yonhap)
MOST POPULAR